Results 241 to 250 of about 265,306 (275)
Advancing design strategies in smart stimulus‐responsive liposomes for drug release and nanomedicine
Schematic illustration of stimulus‐responsive liposomes designed for controlled drug release and nanomedicine. The innermost circle represents different liposomal structures, including unilamellar, multilamellar, and multivesicular liposomes. The middle layer illustrates the responsive phospholipid components.
Yuchen Guo +9 more
wiley +1 more source
Biomaterial design strategies for enhancing mitochondrial transplantation therapy
Biomaterials to facilitate mitochondrial transplantation therapy: biomaterials as barriers to protect mitochondria from pathophysiological microenvironments, like osmotic stress caused by the excessive concentration of calcium ion, reactive oxygen species, and advanced glycation end products; biomaterials integrating with biochemical cues to improve ...
Shaoyang Kang +12 more
wiley +1 more source
This study develops a nano‐enzyme patch (ezPatch) targeting bone interfaces. Utilizing ligand‐to‐metal charge transfer (LMCT) catalysis and bone‐targeting ligands on copper nanosheets, ezPatch simultaneously scavenges reactive oxygen species (ROS) and generates oxygen in situ at bone‐losing sites.
Yi Chen +12 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Scandinavian Journal of Rheumatology, 2005
Reactive arthritis (ReA) was known as Reiter's disease or Fiessinger-Leroy disease for nearly 100 years. However, during the past 30 years the disease has been known as reactive arthritis, a member of the spondyloarthritis family. Despite knowing the initiating event (infection) and genetic constitution (many patients have HLA-B27) of ReA, a model of ...
Rubén Burgos-Vargas +1 more
+6 more sources
Reactive arthritis (ReA) was known as Reiter's disease or Fiessinger-Leroy disease for nearly 100 years. However, during the past 30 years the disease has been known as reactive arthritis, a member of the spondyloarthritis family. Despite knowing the initiating event (infection) and genetic constitution (many patients have HLA-B27) of ReA, a model of ...
Rubén Burgos-Vargas +1 more
+6 more sources
Annual Review of Medicine, 1987
Inflammatory arthritis occurring days to weeks after a localized infection is known as reactive arthritis. Epidemiologic, genetic, and immunologic features have established this disease as a distinct clinicopathologic entity. Although reactive arthritis is often a transient disease, many individuals suffer a chronic relapsing course.
G S, Firestein, N J, Zvaifler
+5 more sources
Inflammatory arthritis occurring days to weeks after a localized infection is known as reactive arthritis. Epidemiologic, genetic, and immunologic features have established this disease as a distinct clinicopathologic entity. Although reactive arthritis is often a transient disease, many individuals suffer a chronic relapsing course.
G S, Firestein, N J, Zvaifler
+5 more sources
Current Opinion in Rheumatology, 1996
The complex interactions between the triggering microbe and the defense mechanisms of the host in reactive arthritis have been studied in several laboratories around the world, and interesting observations have been made. Research has also focused on the mediators in the inflammatory process in joints, and these results are helping to slowly build a ...
A, Toivanen, P, Toivanen
openaire +9 more sources
The complex interactions between the triggering microbe and the defense mechanisms of the host in reactive arthritis have been studied in several laboratories around the world, and interesting observations have been made. Research has also focused on the mediators in the inflammatory process in joints, and these results are helping to slowly build a ...
A, Toivanen, P, Toivanen
openaire +9 more sources
Current Opinion in Rheumatology, 1999
Reactive arthritis is one of the spondyloarthropathy family of clinical syndromes. The clinical features are those shared by other members of the spondyloarthritis family, though it is distinguished by a clear relationship with a precipitating infection.
J, Sieper, J, Braun
openaire +4 more sources
Reactive arthritis is one of the spondyloarthropathy family of clinical syndromes. The clinical features are those shared by other members of the spondyloarthritis family, though it is distinguished by a clear relationship with a precipitating infection.
J, Sieper, J, Braun
openaire +4 more sources
Journal of the European Academy of Dermatology and Venereology, 2014
AbstractReactive arthritis (ReA) is an immune‐mediated seronegative arthritis that belongs to the group of spondyloarthropathies and develops after a gastrointestinal or genitourinary system infection. The condition is considered to be characterized by a triad of symptoms (conjunctivitis, arthritis and urethritis) although a constellation of other ...
P G, Stavropoulos +4 more
openaire +2 more sources
AbstractReactive arthritis (ReA) is an immune‐mediated seronegative arthritis that belongs to the group of spondyloarthropathies and develops after a gastrointestinal or genitourinary system infection. The condition is considered to be characterized by a triad of symptoms (conjunctivitis, arthritis and urethritis) although a constellation of other ...
P G, Stavropoulos +4 more
openaire +2 more sources

